ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Clinical trials for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-stage trial tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and understand side effects. About 102 participants will receive the drug weekly or multiple days per week.
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Kids' brain tumor drug combo gets Long-Term safety check
Disease control Recruiting nowThis study follows children who previously took dabrafenib and/or trametinib for certain brain tumors. It aims to see how safe these drugs are over the long term by tracking side effects and monitoring growth. About 163 children are enrolled, and the study is no longer recruiting…
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC